Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 1997

View Archived Issues

Orally active HNE inhibitors from Cortech effective in lung injury model

Pharmacological profile of selective, orally active PDE IV inhibitor

Mechanism of antiasthmatic action of inhaled furosemide investigated

CytRx and Zynaxis complete merger

Cortex to evaluate CX-516 for the treatment of schizophrenia

Texas Biotechnology reports phase III results with Novastan in HIT and HITTS

Celtrix receives additional U.S. patents

Clinical efficacy and safety of Accolate for asthma

Dusa reports progress in phase III trial of Levulan PDT

RPR and Stanford enter research agreement for drug discovery and gene therapy

Scriptgen and Lilly enter drug discovery collaboration

Antiretroviral therapy and hearing loss

Schwarz Pharma and LocalMed work together on antirestenosis drug

Fluconazole safe and effective for tinea corporis/cruris

NeoPharm reports on antisense liposomes which inhibit Raf-1 proteins

OPC-14117 effective in mouse model of motor neuron disease

AmBisome cleared for marketing in Brazil

Novavax to initiate dose-ranging trial of Helicore

Mylan receives FDA approval of generic captopril/hydrochlorothiazide

Update on PDT's Purlytin

Dusa enters collaboration for Levulan PD of bladder cancer

Improved microtubule-inhibitory anticancer agents in development

FUB-181: Potent and selective H3 antagonist

Promising phase II results for thalidomide in brain cancer and Kaposi's sarcoma

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...